01 1Calyx Chemicals & Pharmaceuticals Limited
02 1Cipla Ltd.
03 1Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
01 1ARTEMETHER
02 2Artemether
01 1China
02 2India
NDC Package Code : 66639-118
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7629
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67254-929
Start Marketing Date : 2013-01-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Artemether manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Artemether, including repackagers and relabelers. The FDA regulates Artemether manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Artemether API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Artemether manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Artemether supplier is an individual or a company that provides Artemether active pharmaceutical ingredient (API) or Artemether finished formulations upon request. The Artemether suppliers may include Artemether API manufacturers, exporters, distributors and traders.
click here to find a list of Artemether suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Artemether as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Artemether API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Artemether as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Artemether and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Artemether NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Artemether suppliers with NDC on PharmaCompass.
We have 3 companies offering Artemether
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
